NCT02474797

Brief Summary

Diaphragmatic dysfunction is associated with sepsis severity and pejorative prognosis. Aim of this study is to assess diaphragmatic function with the Diaphragmatic Thickening Fraction (DTF) ultrasound measure in patients with severe sepsis or septic shock, mechanically ventilated or not, hospitalized in ICU in order to determinate diaphragmatic dysfunction frequency, its prognosis value and its associated factors. This is a prospective pilot study in a 14-bed medical and surgical ICU including 50 consecutive patients with severe sepsis or septic shock. The expected duration of study is 18 months. DTF is measured each day as follow: the probe is placed in an intercostal space between mid axillary line and anterior axillary line, 0.5cm to 2 centimeters below the costodiaphragmatic sinus. DTF measure is performed in B-mode using the following formula: TF (%) = \[(end-inspiration thickness - end-expiration thickness)/(end-expiration thickness) x 100\]. A DTF \< 20% indicates a diaphragmatic dysfunction. The investigators will collect potential factors for which DTF Ultrasound Measure could have a prognosis value (intubation, successful or failed weaning from mechanical ventilation), potential risk factors (age, sex, tobacco, alcohol etc.) and potentials associated factors. The investigators expect measure of DTF allows identifying patient with severe sepsis or septic shock with diaphragmatic dysfunction. It would also estimate diaphragmatic dysfunction frequency with ultrasound measure and warranting its use routinely at the bedside. The investigators expect that DTF helps to characterize degree of severity of septic patient and can be a new index able to predict intubation in this population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at below P25 for not_applicable sepsis

Timeline
Completed

Started May 2015

Longer than P75 for not_applicable sepsis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 4, 2015

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 3, 2015

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 18, 2015

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 8, 2019

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
Last Updated

May 1, 2020

Status Verified

April 1, 2020

Enrollment Period

4.2 years

First QC Date

June 3, 2015

Last Update Submit

April 30, 2020

Conditions

Keywords

UltrasonographyDiaphragmLung ultrasoundSepsisCritical careChest physiotherapy

Outcome Measures

Primary Outcomes (1)

  • Diaphragmatic Dysfunction with DTF Ultrasound measure

    Diaphragmatic dysfunction is defined by DTF \< 20%. Frequency of diaphragmatic dysfunction is measured by the ratio of: number of patient with DTF \< 20% during ICU hospitalization on total number of patients included.

    Participants will be followed for the duration of ICU stay, an expected average of 10 days

Secondary Outcomes (4)

  • Collection of potential factors for which DTF Ultrasound Measure could have a prognosis value: intubation, successful or failed weaning from mechanical ventilation

    Participants will be followed for the duration of ICU stay, an expected average of 10 days

  • Collection of potential risk factors: age, sex, tobacco, alcohol, cirrhosis, diabetes mellitus

    At baseline

  • Collection of potentials associated factors: medication (hypnotics, opioids, steroids, catecholamines), mechanical ventilation, presence of a septic shock, severity score (SOFA), ICU and Hospital Length of stay, ICU and Hospital mortality

    Participants will be followed for the duration of ICU stay, an expected average of 10 days

  • Change in Diaphragmatic Thickening Fraction with DTF Ultrasound measure

    Participants will be followed for the duration of ICU stay, an expected average of 10 days

Study Arms (1)

Diaphragmatic ultrasonography in septic patient

EXPERIMENTAL

Diaphragmatic Thickening Fraction

Device: Diaphragmatic ultrasonography

Interventions

Daily Measure of Diaphragmatic Thickening Fraction (DTF) will be performed by a trained physiotherapist. Physiotherapist (A. LE NEINDRE). The patient will be then instructed to perform breathing to total lung capacity and then to exhale to residual volume, when it is possible (awaken patient). Awakening status will be recorded. Mechanically ventilated patients will be evaluated in Pressure Support (PS) mode (during daily PS mode research for patients with Controlled Ventilation), with the lower PS level tolerated. PS level will be recorded. Thickening fraction (TF) measure is performed in B-mode using the following formula: TF (%) = \[(end-inspiration thickness - end-expiration thickness)/(end-expiration thickness) x 100\]. Diaphragmatic dysfunction is defined like a DTF \< 20% (7).

Also known as: Diaphragmatic sonography
Diaphragmatic ultrasonography in septic patient

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient hospitalized in our Medical/Surgical ICU;
  • Severe sepsis of septic shock (2001 International Sepsis Definition Conference);
  • Age \> 18 years;
  • Patient consent.

You may not qualify if:

  • Preexisting neuromuscular disorders;
  • Recent cardiac or thoracic surgery;
  • Use of neuromuscular blocking agent within the 24h preceding the first diaphragm assessment;
  • Known preexisting diaphragmatic disorders;
  • Cervical spine injury;
  • Refusal to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe Hospitalier Paris Saint-Joseph

Paris, Île-de-France Region, 75014, France

Location

Related Publications (7)

  • Jung B, Nougaret S, Conseil M, Coisel Y, Futier E, Chanques G, Molinari N, Lacampagne A, Matecki S, Jaber S. Sepsis is associated with a preferential diaphragmatic atrophy: a critically ill patient study using tridimensional computed tomography. Anesthesiology. 2014 May;120(5):1182-91. doi: 10.1097/ALN.0000000000000201.

    PMID: 24608360BACKGROUND
  • Supinski GS, Callahan LA. Diaphragm weakness in mechanically ventilated critically ill patients. Crit Care. 2013 Jun 20;17(3):R120. doi: 10.1186/cc12792.

    PMID: 23786764BACKGROUND
  • Demoule A, Jung B, Prodanovic H, Molinari N, Chanques G, Coirault C, Matecki S, Duguet A, Similowski T, Jaber S. Diaphragm dysfunction on admission to the intensive care unit. Prevalence, risk factors, and prognostic impact-a prospective study. Am J Respir Crit Care Med. 2013 Jul 15;188(2):213-9. doi: 10.1164/rccm.201209-1668OC.

    PMID: 23641946BACKGROUND
  • Santos PD, Teixeira C, Savi A, Maccari JG, Neres FS, Machado AS, de Oliveira RP, Ribeiro M, Rotta FT. The critical illness polyneuropathy in septic patients with prolonged weaning from mechanical ventilation: is the diaphragm also affected? A pilot study. Respir Care. 2012 Oct;57(10):1594-601. doi: 10.4187/respcare.01396. Epub 2012 Mar 13.

    PMID: 22417531BACKGROUND
  • Bouhemad B, Zhang M, Lu Q, Rouby JJ. Clinical review: Bedside lung ultrasound in critical care practice. Crit Care. 2007;11(1):205. doi: 10.1186/cc5668.

    PMID: 17316468BACKGROUND
  • Matamis D, Soilemezi E, Tsagourias M, Akoumianaki E, Dimassi S, Boroli F, Richard JC, Brochard L. Sonographic evaluation of the diaphragm in critically ill patients. Technique and clinical applications. Intensive Care Med. 2013 May;39(5):801-10. doi: 10.1007/s00134-013-2823-1. Epub 2013 Jan 24.

    PMID: 23344830BACKGROUND
  • Summerhill EM, El-Sameed YA, Glidden TJ, McCool FD. Monitoring recovery from diaphragm paralysis with ultrasound. Chest. 2008 Mar;133(3):737-43. doi: 10.1378/chest.07-2200. Epub 2008 Jan 15.

    PMID: 18198248BACKGROUND

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Aymeric Le Neindre, PT, MSc

    Fondation Hôpital Saint-Joseph

    PRINCIPAL INVESTIGATOR
  • François Philippart, MD, PhD

    Fondation Hôpital Saint-Joseph

    PRINCIPAL INVESTIGATOR
  • Benoît Misset, MD, PhD

    Fondation Hôpital Saint-Joseph

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2015

First Posted

June 18, 2015

Study Start

May 4, 2015

Primary Completion

July 8, 2019

Study Completion

April 1, 2020

Last Updated

May 1, 2020

Record last verified: 2020-04

Locations